Lot quality assurance sampling for coverage evaluation of a new vaccine: A pilot study

IF 2.7 Q3 IMMUNOLOGY Vaccine: X Pub Date : 2024-11-01 DOI:10.1016/j.jvacx.2024.100578
Rhythm Hora , Arindam Ray , Imkongtemsu Longchar , G.R. Rio , Rashmi Mehra , Seema Singh Koshal , Amrita Kumari , Syed F. Quadri , Amanjot Kaur , Arup Deb Roy
{"title":"Lot quality assurance sampling for coverage evaluation of a new vaccine: A pilot study","authors":"Rhythm Hora ,&nbsp;Arindam Ray ,&nbsp;Imkongtemsu Longchar ,&nbsp;G.R. Rio ,&nbsp;Rashmi Mehra ,&nbsp;Seema Singh Koshal ,&nbsp;Amrita Kumari ,&nbsp;Syed F. Quadri ,&nbsp;Amanjot Kaur ,&nbsp;Arup Deb Roy","doi":"10.1016/j.jvacx.2024.100578","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Worldwide, vaccine-preventable diseases have been a significant cause of mortality in the under-5 age group. To reduce the disease burden, new vaccines are being introduced in every country’s immunization programmes. For this to happen, high vaccination coverage is necessary. However, rapidly identifying the areas that fail to reach the expected coverage becomes cumbersome. During recent years, lot quality assurance sampling (LQAS) has been widely used in evaluating immunization coverage across the globe. The present study aims to pilot this approach for field monitoring of a new vaccine against routine concurrent field monitoring in one of the North-Eastern states of India.</div></div><div><h3>Methodology</h3><div>For LQAS, a community-based cross-sectional study was undertaken among 55 children aged 0–23 months in all 5 Primary health centres (lots) of Medziphema block, Dimapur, Nagaland. The total sample size for LQAS was calculated based on α = 5, β = 90 using Lemeshow and Taber-LQAS table with a target level of immunization defined as 90 % and the lower limit set to 55 %. For the concurrent field monitoring, a sample of 30 children in the same age group was selected through random sampling. Pre-designed, pre-tested questionnaire for the caregivers, scripted on a digital tool was employed with verification of immunization card and caregiver’s recall. Data was analyzed using SPSS software version 25.0.</div></div><div><h3>Results</h3><div>The study found a slight difference in the percentage of children age-appropriately vaccinated for PCV (as per the schedule) in concurrent field monitoring (93.3 %) and LQAS (90.9 %). However, no statistically significant difference was found in comparing the immunization coverage using both methodologies (p &gt; 0.05).</div></div><div><h3>Conclusion</h3><div>The study findings encourage that LQAS can be considered for monitoring the immunization coverage of a newly introduced vaccine. It offers the added advantage of identifying poor/low-performing pockets that require focused attention.</div></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"21 ","pages":"Article 100578"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136224001517","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Worldwide, vaccine-preventable diseases have been a significant cause of mortality in the under-5 age group. To reduce the disease burden, new vaccines are being introduced in every country’s immunization programmes. For this to happen, high vaccination coverage is necessary. However, rapidly identifying the areas that fail to reach the expected coverage becomes cumbersome. During recent years, lot quality assurance sampling (LQAS) has been widely used in evaluating immunization coverage across the globe. The present study aims to pilot this approach for field monitoring of a new vaccine against routine concurrent field monitoring in one of the North-Eastern states of India.

Methodology

For LQAS, a community-based cross-sectional study was undertaken among 55 children aged 0–23 months in all 5 Primary health centres (lots) of Medziphema block, Dimapur, Nagaland. The total sample size for LQAS was calculated based on α = 5, β = 90 using Lemeshow and Taber-LQAS table with a target level of immunization defined as 90 % and the lower limit set to 55 %. For the concurrent field monitoring, a sample of 30 children in the same age group was selected through random sampling. Pre-designed, pre-tested questionnaire for the caregivers, scripted on a digital tool was employed with verification of immunization card and caregiver’s recall. Data was analyzed using SPSS software version 25.0.

Results

The study found a slight difference in the percentage of children age-appropriately vaccinated for PCV (as per the schedule) in concurrent field monitoring (93.3 %) and LQAS (90.9 %). However, no statistically significant difference was found in comparing the immunization coverage using both methodologies (p > 0.05).

Conclusion

The study findings encourage that LQAS can be considered for monitoring the immunization coverage of a newly introduced vaccine. It offers the added advantage of identifying poor/low-performing pockets that require focused attention.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于新型疫苗覆盖率评估的批次质量保证抽样:试点研究
背景在全球范围内,疫苗可预防的疾病一直是 5 岁以下儿童死亡的重要原因。为了减轻疾病负担,各国都在免疫接种计划中引入了新疫苗。为此,疫苗接种的高覆盖率是必要的。然而,快速确定未能达到预期覆盖率的地区变得非常麻烦。近年来,批次质量保证抽样(LQAS)已在全球范围内广泛用于评估免疫接种覆盖率。本研究的目的是在印度东北部的一个邦试点采用这种方法对一种新疫苗进行实地监测,并与常规的同步实地监测相比较。方法为了进行批次质量保证抽样,我们在那加兰邦大马普尔市 Medziphema 区的所有 5 个初级保健中心(批次)的 55 名 0-23 个月大的儿童中开展了一项基于社区的横断面研究。LQAS 的总样本量是根据 Lemeshow 和 Taber-LQAS 表中的 α = 5、β = 90 计算得出的,目标免疫接种率为 90%,下限为 55%。在同时进行的实地监测中,通过随机抽样选取了同一年龄组的 30 名儿童作为样本。采用了预先设计、预先测试的护理人员调查问卷,问卷以数字工具为脚本,并对免疫接种卡和护理人员的回忆进行了核实。研究发现,在同时进行的实地监测(93.3%)和 LQAS(90.9%)中,适龄儿童接种 PCV(按计划)的比例略有不同。结论研究结果表明,LQAS 可用于监测新引进疫苗的免疫接种覆盖率。它还具有识别需要重点关注的不良/低效地区的优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Vaccine: X
Vaccine: X Multiple-
CiteScore
2.80
自引率
2.60%
发文量
102
审稿时长
13 weeks
期刊最新文献
Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi The cost-effectiveness of COVID-19 vaccination program among age-groups children, adults, and elderly in Europe: A systematic review COVID-19 vaccine or booster uptake and hesitancy for children aged 6 months–5 years in the United States: A national descriptive study using the household pulse survey between March and May 2023 Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study Lot quality assurance sampling for coverage evaluation of a new vaccine: A pilot study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1